- Home
- IMSR vs HQL Comparison
IMSR vs HQL Comparison
Compare IMSR & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | IMSR | HQL |
|---|---|---|
| Founded | 2013 | 1992 |
| Country | United States | United States |
| Employees | 74 | N/A |
| Industry | | Investment Managers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 571.5M | 585.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IMSR | HQL |
|---|---|---|
| Price | $5.53 | $20.65 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 155.5K |
| Earning Date | 05-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $26.10 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.38 | $13.22 |
| 52 Week High | $16.38 | $21.32 |
Technical Indicators
Market Signals| Indicator | IMSR | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 49.07 | 66.91 |
| Support Level | $5.33 | $16.51 |
| Resistance Level | $5.64 | $21.32 |
| Average True Range (ATR) | 0.40 | 0.42 |
| MACD | 0.15 | 0.07 |
| Stochastic Oscillator | 72.94 | 93.75 |
Price Performance
Historical ComparisonAbout IMSR Terrestrial Energy Inc.
Terrestrial Energy Inc is a technology company engaged in the development and commercialization of nuclear power plants. The company is focused on its proprietary Integral Molten Salt Reactor (IMSR) technology, a Generation IV reactor design intended to produce reliable, emission-free energy in the form of electricity and high-temperature heat for industrial applications. Its activities mainly involve advancing the design, licensing, and deployment of IMSR plants for commercial energy generation.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.